MedPacto, Inc. (KOSDAQ:235980)
5,650.00
-220.00 (-3.75%)
At close: Feb 6, 2026
MedPacto Market Cap
MedPacto has a market cap or net worth of 193.65 billion as of February 6, 2026. Its market cap has increased by 15.90% in one year.
Market Cap
193.65B
Enterprise Value
152.11B
Revenue
2.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,650.00
Market Cap Chart
Since December 19, 2019, MedPacto's market cap has decreased from 362.50B to 193.65B, a decrease of -46.58%. That is a compound annual growth rate of -9.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 193.65B | -15.42% |
| Dec 30, 2025 | 228.96B | 50.62% |
| Dec 30, 2024 | 152.01B | -37.48% |
| Dec 28, 2023 | 243.12B | -48.17% |
| Dec 29, 2022 | 469.05B | -60.97% |
| Dec 30, 2021 | 1.20T | -49.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JETEMA, | 348.91B |
| Bioneer | 325.98B |
| Helixmith | 279.04B |
| EASY BIO,Inc. | 248.78B |
| HLB Therapeutics | 241.80B |
| Genexine | 201.02B |
| Macrogen | 188.10B |
| ENCell | 181.90B |